New Diagnostic Collection and Transport Systems Unveiled
|
By LabMedica International staff writers Posted on 30 Apr 2012 |

Image: Puritan UTM and Puritan Liquid Amies diagnostic collection and transport systems (Photo courtesy Puritan Medical Products Co. LLC).
A medical products company has launched two liquid-based multipurpose collection and transport systems for diagnostic use.
The Universal Transport Media (UTM) Transport System contains a multipurpose medium allowing for transport and maintenance of clinically relevant viruses and bacteria at room temperature. Medical grade plastic components with a leak proof, self-centering cap feature facilitate easy removal and disposal of the swabs.
The Liquid Amies Transport Systems is a self-contained, ready-to-use multipurpose collection and transport system for aerobes, anaerobes, and fastidious bacteria up to 48 hours at room temperature. It is an ideal system designed to accommodate both automation and traditional liquid specimen processing in clinical laboratories, including culturing and Gram staining.
The UIM system has recently received 510k approval in the United States, and approval for the Liquid Amies system is pending. Both systems are approved for sale in Europe.
Entirely manufactured by Puritan Medical Products (Guilford, ME, USA) the systems are the crucial first step in the diagnosis of bacterial and viral infections and designed to facilitate safe and effective preanalytical specimen collection and transport to the laboratory. Puritan Medical Products Co. LLC Medical products launched its two liquid-based multipurpose collection and transport systems for diagnostic use through its newly created division, Puritan Diagnostics Company, LLC.
Puritan swabs are easy to use, with tips in various sizes to accommodate various sampling sites, such as nose, throat, and wounds. All handles have premolded break points for ease of use with a self-centering cap and soon will have custom handle imprinting.
Puritan's executive vice president for global sales, Timothy Templet, noted, "The new systems are available with our pure non-yellowing, patent-pending flocked swabs, which collect and elute the sample into the transport liquid better than most competing swabs." He added that a major aspect of both new collection systems is "our ability to provide contract manufacturing and work closely with our customers to create custom liquid solutions to meet essential clinical specimen collection and transport needs."
Related Links:
Puritan Medical Products
The Universal Transport Media (UTM) Transport System contains a multipurpose medium allowing for transport and maintenance of clinically relevant viruses and bacteria at room temperature. Medical grade plastic components with a leak proof, self-centering cap feature facilitate easy removal and disposal of the swabs.
The Liquid Amies Transport Systems is a self-contained, ready-to-use multipurpose collection and transport system for aerobes, anaerobes, and fastidious bacteria up to 48 hours at room temperature. It is an ideal system designed to accommodate both automation and traditional liquid specimen processing in clinical laboratories, including culturing and Gram staining.
The UIM system has recently received 510k approval in the United States, and approval for the Liquid Amies system is pending. Both systems are approved for sale in Europe.
Entirely manufactured by Puritan Medical Products (Guilford, ME, USA) the systems are the crucial first step in the diagnosis of bacterial and viral infections and designed to facilitate safe and effective preanalytical specimen collection and transport to the laboratory. Puritan Medical Products Co. LLC Medical products launched its two liquid-based multipurpose collection and transport systems for diagnostic use through its newly created division, Puritan Diagnostics Company, LLC.
Puritan swabs are easy to use, with tips in various sizes to accommodate various sampling sites, such as nose, throat, and wounds. All handles have premolded break points for ease of use with a self-centering cap and soon will have custom handle imprinting.
Puritan's executive vice president for global sales, Timothy Templet, noted, "The new systems are available with our pure non-yellowing, patent-pending flocked swabs, which collect and elute the sample into the transport liquid better than most competing swabs." He added that a major aspect of both new collection systems is "our ability to provide contract manufacturing and work closely with our customers to create custom liquid solutions to meet essential clinical specimen collection and transport needs."
Related Links:
Puritan Medical Products
Latest Technology News
- AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
- Agentic AI Platform Supports Genomic Decision-Making in Oncology
- Algorithm Panel Aids Liver Fibrosis Assessment and Liver Cancer Surveillance
- Mailed Screening Kits Help Reduce Colorectal Cancer Screening Gaps
- AI-Enabled Assistant Unifies Molecular Workflow Planning and Support
- AI Tool Automates Validation of Laboratory Software Configuration Changes
- Point-of-Care Testing Enhances Health Literacy and Self-Management in Chronic Disease
- Fully Automated Sample-to-Insight Workflow Advances Latent TB Testing
- Tumor-on-a-Chip Platform Models Pancreatic Cancer Treatment Response
- New Platform Captures Extracellular Vesicles for Early Cancer Detection
- Microfluidic Single-Cell Assay Predicts Breast Cancer Risk
- AI Tool Predicts Non-Response to Targeted Therapy in Colorectal Cancer
- Integrated System Streamlines Pre-Analytical Workflow for Molecular Testing
- Noninvasive Sputum Test Detects Early Lung Cancer
- New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
- Rapid Biosensor Detects Drug Sensitivity in Breast Tumors
Channels
Clinical Chemistry
view channel
Saliva-Based Test Detects Biochemical Signs of Sleep Loss
Acute sleep loss impairs cognition and motor skills, raising safety risks that resemble alcohol intoxication. Clinicians currently lack an objective biochemical test to determine when someone is dangerously... Read more
Simple Dual-Tau Blood Test Detects and Stages Alzheimer’s Disease
Alzheimer’s disease is typically confirmed and staged with positron emission tomography scans and cerebrospinal fluid testing, procedures that are costly and invasive. Broader access to minimally invasive... Read more
Alzheimer’s Blood Biomarkers Linked to Early Cognitive Differences Before Dementia
Blood-based screening for Alzheimer’s disease offers a noninvasive, lower-cost alternative to brain imaging or spinal fluid testing, yet its ability to flag the earliest cognitive changes has been unclear.... Read moreMolecular Diagnostics
view channel
Blood Test Predicts Immunotherapy Response in Head and Neck Cancer
Head and neck squamous cell carcinoma affects hundreds of thousands of people worldwide each year, yet response rates to immunotherapy remain low. Clinicians lack reliable, minimally invasive tools to... Read more
New PCR Assay Supports Bundibugyo Ebola Outbreak Surveillance
Rapid identification of Ebola infections is essential to limit transmission and guide public health response, yet detection can be difficult when outbreaks involve rare variants. The current outbreaks... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channelAptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read moreMicrobiology
view channel
New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
Clostridioides difficile infections remain a persistent threat in hospitals and communities, affecting about 500,000 people in the United States each year. Severe cases can be fatal within 30 days of diagnosis,... Read more
Automated Blood Culture System Speeds Detection of Bloodstream Infections
Bloodstream infections and sepsis require rapid laboratory detection to guide targeted antimicrobial therapy and reduce mortality. Conventional blood culture workflows can delay actionable results by critical... Read morePathology
view channel
3D Spatial Multi-Omics Maps Intra-Tumor Diversity in Colorectal Cancer
Colorectal cancer remains a leading cause of cancer death, and clinical decision-making is complicated by marked intra-tumor heterogeneity. Conventional bulk sequencing averages molecular signals across... Read more
Blood-Based Method Tracks Gene Activity in the Living Brain
Real-time measurement of gene activity in the brain has been limited by assays requiring destructive tissue sampling. Tracking active genes could reveal how the body responds to environmental factors,... Read moreIndustry
view channel
Collaboration Advances ctDNA-Guided Development in Metastatic Colorectal Cancer
Natera, Inc. (Austin, TX, USA) and CytoDyn Inc. (Vancouver, WA, USA) announced a strategic collaboration focused on metastatic colorectal cancer (mCRC). Under the agreement, Natera will evaluate circulating... Read more








